Cargando…
SARS-CoV-2 vaccines: Lights and shadows
Vaccines to prevent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicit an immune neutralizing response. Some concerns have been raised regarding the safety of SARS-CoV-2 vaccines, largely based on case-reports of serious thromboembolic events after vaccination. Some mechanisms ha...
Autores principales: | Angeli, Fabio, Spanevello, Antonio, Reboldi, Gianpaolo, Visca, Dina, Verdecchia, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084611/ https://www.ncbi.nlm.nih.gov/pubmed/33966930 http://dx.doi.org/10.1016/j.ejim.2021.04.019 |
Ejemplares similares
-
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
por: Zappa, Martina, et al.
Publicado: (2021) -
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
por: Angeli, Fabio, et al.
Publicado: (2021) -
COVID-19, vaccines and deficiency of ACE(2) and other angiotensinases. Closing the loop on the "Spike effect"
por: Angeli, Fabio, et al.
Publicado: (2022) -
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
por: Verdecchia, Paolo, et al.
Publicado: (2020) -
The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure()
por: Angeli, Fabio, et al.
Publicado: (2023)